About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Insulin icodec
- Company
- Novo Nordisk A/S
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 6 recruiting
Efficacy results: Not yet reported
6 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Sep 16, 2026
Find a Clinical Trial Near Me
See recruiting studies for Insulin icodec and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT06807190
General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus
Novo Nordisk A/S 630 participants Est. completion 2028-01-31 116 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Recruiting NCT NCT07112339
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 586 participants Est. completion 2028-03-23 75 sites Stand-aloneType 2 diabetesView official trial listing → -
Recruiting NCT NCT07146347
Comparison Study of Insulin GZR4 With Insulin Degludec
Not yet reported Gan and Lee Pharmaceuticals, USA 14 participants Est. completion 2026-06-01 1 site Stand-aloneType 2 diabetesView official trial listing → -
Recruiting NCT NCT07165223
A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Not yet reported Gan & Lee Pharmaceuticals. 300 participants Est. completion 2026-11-10 1 siteOther conditions: DiabetesView official trial listing → -
Recruiting NCT NCT07591519
Clinical Trials of IBI3035 in Healthy Subjects
Not yet reported Innovent Biologics (Suzhou) Co. Ltd. 144 participants Est. completion 2027-08-31 1 site Stand-aloneOther conditions: Healthy PersonView official trial listing → -
Recruiting NCT NCT07630233
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males
Not yet reported The United Bio-Technology (Hengqin) Co., Ltd. 53 participants Est. completion 2026-10-25 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02148861
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 49 participants Est. completion 2015-06-01 1 site Stand-aloneType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT02964104
A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 50 participants Est. completion 2017-12-12 1 site Stand-aloneType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT03723772
A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week
Not yet reported Novo Nordisk A/S 66 participants Est. completion 2020-06-26 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03723785
A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems
Not yet reported Novo Nordisk A/S 58 participants Est. completion 2019-09-06 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03751657
A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
Not yet reported Novo Nordisk A/S 247 participants Est. completion 2020-01-17 49 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03766854
A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week
Not yet reported Novo Nordisk A/S 24 participants Est. completion 2019-12-09 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03922750
A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine
Not yet reported Novo Nordisk A/S 154 participants Est. completion 2020-01-27 38 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03945656
A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 43 participants Est. completion 2021-09-27 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03951805
A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before
Not yet reported Novo Nordisk A/S 205 participants Est. completion 2020-01-17 43 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04460885
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before
Not yet reported Novo Nordisk A/S 984 participants Est. completion 2022-12-01 198 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04582435
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 46 participants Est. completion 2022-04-22 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04582448
A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 25 participants Est. completion 2021-09-27 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04597697
A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver Disease
Not yet reported Novo Nordisk A/S 25 participants Est. completion 2022-03-24 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04760626
A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
Not yet reported Novo Nordisk A/S 1085 participants Est. completion 2022-08-29 311 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04770532
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin
Not yet reported Novo Nordisk A/S 526 participants Est. completion 2022-03-01 88 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04795531
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)
Not yet reported Novo Nordisk A/S 588 participants Est. completion 2022-06-23 190 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04848480
A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)
Not yet reported Novo Nordisk A/S 582 participants Est. completion 2022-12-02 130 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT04857398
A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 24 participants Est. completion 2022-04-06 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04880850
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)
Not yet reported Novo Nordisk A/S 582 participants Est. completion 2022-06-16 116 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT05013229
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
Not yet reported Novo Nordisk A/S 679 participants Est. completion 2023-11-14 182 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT05259033
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
Not yet reported Novo Nordisk A/S 683 participants Est. completion 2024-01-16 193 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT05352815
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
Not yet reported Novo Nordisk A/S 1291 participants Est. completion 2024-04-23 281 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT05435677
A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together
Not yet reported Novo Nordisk A/S 20 participants Est. completion 2023-04-25 1 site Added to GLP-1Type 2 diabetesView official trial listing → -
Completed NCT NCT05790681
A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers
Not yet reported Novo Nordisk A/S 18 participants Est. completion 2024-02-08 21 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT05813912
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 148 participants Est. completion 2025-05-16 39 sites Added to GLP-1Type 2 diabetesView official trial listing → -
Completed NCT NCT05823948
A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
Not yet reported Novo Nordisk A/S 51 participants Est. completion 2024-04-11 20 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT06269107
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
Not yet reported Novo Nordisk A/S 485 participants Est. completion 2025-07-08 118 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT06288412
A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting
Not yet reported Novo Nordisk A/S 30 participants Est. completion 2025-04-14 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT06340854
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 412 participants Est. completion 2025-06-13 83 sites Stand-aloneOther conditions: Diabetes, Type 2View official trial listing → -
Active, not recruiting NCT NCT07076199
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Not yet reported Novo Nordisk A/S 877 participants Est. completion 2027-03-01 182 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Active, not recruiting NCT NCT07160816
A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar
Novo Nordisk A/S 245 participants Est. completion 2027-01-20 37 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Not yet recruiting NCT NCT07632404
A Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
Novo Nordisk A/S 214 participants Est. completion 2027-12-01 15 sitesType 2 diabetesView official trial listing → -
Enrolling by invitation NCT NCT07658417
Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
Novo Nordisk A/S 216 participants Est. completion 2027-12-01 15 sitesType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07747402
Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
Not yet reported Xi'an International Medical Center Hospital 462 participants Est. completion 2028-03 1 site Stand-aloneType 2 diabetesView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Insulin icodec, Insulin Icodec Injection
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.